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Hypogastric Preservation With Branch Endograft Ver-
sus Exclusion for Aorto-iliac Aneurysms
Giovanni Pratesi1, Aaron Fargion2, Lorenzo Di Giulio1, Ar-
naldo Ippoliti1, Carlo Pratesi2. 1Department of Surgery -Unit
of Vascular Surgery, University of Rome Tor Vergata, Rome,
Italy; 2Department of Medical-Surgical Critical Area, Unit of
Vascular Surgery, University of Florence, Florence, Italy
Objectives: To analyze early and midterm results of
endovascular treatment of aorto-iliac aneurysm extending
to the iliac bifurcation, by comparing the results of hypo-
gastric preservation with iliac branched endograft vs hypo-
gastric exclusion.
Methods: All consecutive patients underwent EVAR
for aorto-iliac aneursym between January 2000 and Sep-
tember 2009 were included in the analysis. Patients under-
going hypogastric artery preservation with iliac branched
device (Group 1) were compared with those treated by
standard endograft and hypogastric exclusion (Group 2).
Results: A total of 78 patients (72 male, mean age, 78.4
years) were treated: 23 in Group 1 and 55 in Group 2. No
differences in baseline risk factors and aneurysmdiameterwere
found. Technical success of the procedure was 100% in both
groups. No death occurred. There were no cases of intestinal
ischemia in Group 1 compare with 2/55 (3.6%) in Group 2
(p .03). No occlusions of internal iliac branches were noted.
Survival (100% Group 1 vs 97.6% Group 2, p .1), endoleak
(88.1% Group 1 vs 87.5% Group 2, p .7), reintervention
(97.6% Group 1 vs 94.4% Group 2, p .2) and common iliac
aneurysm shrinkage (26.1%Group1 vs 23.6%Group2, p .09)
at two years were similar in both groups. Buttock claudication
or impotence was more frequent after hypogastric exclusion
(4.3% Group 1 vs 21.8% Group 2, p. 04).
Conclusions: Iliac branch endograft may avoid poten-
tial pelvic ischemic complication and enhance procedural
safety for patients undergoing endovascular repair of aorto-
iliac aneurysms.
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When Is Conservative Management of Primary Type Ia
Endoleaks Justified?
JasperW. van Keulen1, Hence J. Verhagen2, Kim de Roode1,
Frans L. Moll1, Joost A. van Herwaarden1. 1UMC Utrecht,
Utrecht, Netherlands; 2Erasmus, Rotterdam, Netherlands
Objectives: Direct additional therapy is advised for
type Ia endoleaks (EL) detected on completion angiogra-
phy after EVAR. Additional endovascular procedures to
treat these ELs are often challenging/impossible, and con-
version is unattractive. The objective is to analyze theresults of a conservative strategy for a selected subgroup of
patients with a primary type Ia EL.
Methods: If a primary type Ia EL is detected in our
hospital, the stentgraft is placed at the intended position,
the sealing zone in the AAA neck is more 10mm (45d
angulation) or 15 mm (60d), and the stentgraft is
10% oversized, a wait-and-see strategy is followed. We
retrieved all patients with a primary type Ia EL out of our
EVAR database (2004-2009). Medical records were ana-
lyzed and AAA neck morphology was quantified. Type Ia
EL patients with for EVAR suitable anatomy, stentgraft
oversizing of 10%, and graft deployment at the planned
position were included. Complications during follow-up
were studied and all sequential CTAs were reviewed.
Results: 15 patients were included with a median AAA
diameter of 60mm (48-80), an AAA neck diameter of 25mm
(20-32), a neck length of 24mm (11-39), and an infrarenal
angulation of 49d (31-90). 8/15 type I ELs had disappeared
spontaneously on the 1st postoperative CTA, obtainedwithin
1week after EVAR.On the 2nd postoperativeCTA, obtained
a median of 4 months (1-7) after EVAR, all type I ELs had
sealed. In 1 patient the AAA ruptured 2 days after EVAR. No
recurrences of type Ia ELs were seen during a follow-up of 22
months (2 days-54months). 2 patients underwent reinterven-
tion, 1 for neck dilatation at 13 months and one for graft
migration at 12 months.
Conclusions: The vast majority of primary proximal
type Ia ELs in this selected subgroup sealed spontaneously,
and did not re-occur. Until sealing, there is a risk for
rupture, but after sealing no recurrences were seen. A
conservative approach of this type Ia ELs in this specific
patient group may be justified.
Author Disclosures: K. de Roode: Nothing to disclose;
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In Vivo Assessment of Thoracic Aortic Compliance:
Implications for Endograft Design
Tyler S. Reynolds1, Karen M. Kim1, Carlos E. Donayre1,
George E. Kopchok1, Irwin Walot2, Joe P. Chauvapun1,
Rodney A. White1. 1Department of Vascular Surgery, Har-
bor UCLAMedical Center, Torrance, CA; 2Department of
Interventional Radiology, Harbor UCLA Medical Center,
Torrance, CA
Objectives: Compliance of the adult thoracic aorta has
not been studied in vivo in patients with aortic disease. This
is the first study to assess this parameter across the spectrum
of aortic disease.
Methods: 42 patients undergoing thoracic aortic
endovascular procedures were evaluated with intravascu-
lar ultrasound of the aorta at the brachiocephalic trunk
and left common carotid. Compliance (C) was calculated
from the mean short axis diameter over 3 cardiac cycles
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x (	P)]x 104.
Results: Compliance of the ascending aorta (17.5 %/100
mm Hg) and aortic arch (16.7) were similar within a single
patient but differed among disease subgroups. (Table 1) Com-
pliance decreased with age by 0.38 0.09 (p 0.05) per yr in
the ascending aorta and 0.47  0.08 (p  0.05) per yr in the
aortic arch.Thedecreasewasmore rapid for chronic dissection at
0.89 per yr (95% CI 1.4-0.4, p 0.05). Compliance increased
withdiameter (p0.05)unless age-adjusted (p0.15) andwas
higher in the transectiongroup than aneurysmorulcer groups (p
 0.05). Compliance measured within a fully deployed en-
dograft in 3 patients was 5.6 (range 1.7-8.7).
Conclusions: Ascending and aortic arch compliance is
significantly higher than reported for peripheral vessels.
Compliance decreases with age, atherosclerotic disease, and
placement of endograft. Differences in compliance of native
aorta may have implications on device design and long-
term performance.
Table 1
Diagnosis n
Ascending aorta Aortic arch
Mean 95% CI Mean 95% CI
Acute Dissection 14 17.9 12.0-23.8 16.2 11.5-20.1
Chronic Dissection 13 20.7 13.9-27.5 20.6 10.2-31.1
Thoracic Aneurysm 4 6.9 0-15.4 9.1 0.04-17.8
Transection 4 26.8 6.6-47.0 21.2 16.0-26.4
Penetrating Ulcer 3 5.8 0-13.8 6.2 0-13.8
No Disease 1 14.0 n/a 24.7 n/a
All Patients (no
prior endograft)
39 17.5 13.8-21.2 16.7 13.0-20.4
Post-deployment
Endograft
3 5.6 Range 1.67-8.7
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Female and Elderly AAA Patients More Commonly
Develop Concurrent Thoracic Aortic Aneurysm
Emma Larsson, Carl Magnus Wahlgren, Jesper Swedenborg,
Rebecka Hultgren. Dep of Molecular Medicine and Surgery
and Dep of Vascular Surgery, Karolinska Institutet and Karo-
linska University Hospital, Stockholm, Sweden
Objectives: The prevalence of thoracic aortic disease
in patients with abdominal aortic aneurysm (AAA) is
unknown. A recent report revealed that one fourth of
AAA patients have a concurrent aneurysm in the thoracic
aorta (TAA). It remains to be investigated which AAA
patients that have a higher risk of developing TAA. The
aim was to identify possible differences in the risk factor
profile in AAA patients with or without a TAA.Methods: All AAA patients, with abdominal and
thoracic computed tomography (CT), attending outpa-
tient clinic at a university hospital, were included (n 
354). Image analysis and hospital chart review were
conducted. The association of comorbidity and TAA was
estimated by logistic regression and odds ratio’s (OR)
with corresponding 95% confidence intervals (CI’s).
Gender specific and neutral criterions were used.
Results: 94 (27%) of 354 AAA patients had a con-
current descending TAA (AAA/TAA). AAA/TAA pa-
tients were older compared to only AAA patients (77 vs
73 years, p 0.001). More women were identified in the
AAA/TAA group (39% vs 16% 0.001). In the logistic
regressionmodel, female sex (OR3.3,CI: 1.9-5.6), hyperten-
sion (OR 1.8, CI 1.1-3.0) and age (70-79 years OR 2.4, CI
1.3-4.6; 80-89 years: OR 3.0, CI 1.5-6.0) were associated
with concurrent TAA (p  0.001). After adjustment only
female gender and age were associated with TAA.
Conclusions: Surveillance of AAA patients must im-
prove to enhance identification of the large group of
patients who has developed, or will develop, concurrent
TAA. This report identifies female sex and increasing age
as factors to consider when analyzing AAA patients at
risk of concurrent TAA. Future studies should address
improved prevention for these patients.
Author Disclosures: R. Hultgren: Nothing to disclose;
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Long-term Results of Talent Endografts for Endovas-
cular Abdominal Aortic Aneurysm Repair
Bart Verhoeven1, Evert Waasdorp2, Joost A. van Herwaar-
den2, Rob van deMortel1, Frans Moll2, Christopher Zarins3,
Jean Paul de Vries1. 1Vascular surgery, St. antonius hospital,
Nieuwegein, Netherlands; 2University Medical Center Utre-
cht, Utrecht, Netherlands; 3Stanford Hospital, Stanford, CA
Objectives: Since introduction of EVAR, long-term
follow-up studies reporting single device results are scarce.
In this study we focus on the Talent® endograft.
Methods: Between July 2000 and December 2007 366
patients underwent elective EVAR repair. Patient data were
gathered prospectively and retrospectively evaluated. 74% of
the patients were diagnosed ASA III and IV. Postoperative
CT-scanning was performed before discharge, 6, 12 months
and yearly thereafter. Data are presented according to report-
ing standards for EVAR (Chaikof et.al, J VS 2002).
Results: Mean proximal aortic neck diameter was 27
mm, with a neck length 15 mm in 31% (data available
for 193 cases). Deployment of endografts was successful
in 99% (362/366) of patients. Initially conversion to
laparotomy was necessary in 4 cases. Primary technical
success based upon results from CT-scans before dis-
charge was achieved in 91% (332/366). 8% (28/366) pa-
tients hadproximal type 1 endoleaks; during follow-up14/28
